Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$335.59 USD

335.59
1,340,140

+0.91 (0.27%)

Updated May 10, 2024 04:00 PM ET

After-Market: $335.75 +0.16 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (48 out of 251)

Industry: Medical - HMOs

Better trading starts here.

Brokerage Reports

Research for HUM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Humana Inc. [HUM]

Reports for Purchase

Showing records 621 - 640 ( 659 total )

Company: Humana Inc.

Industry: Medical - HMOs

Record: 621

07/14/2011

Daily Note

Pages: 33

Healthcare Services - Managed Care: Bullish 2Q11 Outlook

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 622

05/18/2011

Company Report

Pages: 9

Price: 24.95

Company: Humana Inc.

Industry: Medical - HMOs

Record: 623

05/03/2011

Company Report

Pages: 13

Raising 2011E to $7.09 and PT to $87; Continue To See Margin Upside for 2011- Realignment Highlights LT Growth Opportunity

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 50.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 624

05/02/2011

Company Report

Pages: 5

Humana Changes Reporting Segments, Increases Share Repurchase, Declares Dividend

Provider: J.J.B. Hilliard, W.L. Lyons

Analyst: O'NEIL S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 625

05/02/2011

Daily Note

Pages: 6

Pre-Announcement - Guidance Raised

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 626

04/26/2011

Daily Note

Pages: 5

Pre-Announcement $1.86

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 627

04/11/2011

Company Report

Pages: 7

Raising Price Target to $79 in Connection with 1Q11 Preview Based on Updated MA and PDP Enrollment Data Above our Estimates

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 628

03/15/2011

Industry Report

Pages: 7

CMS March Medicare Data Shows Humana Continues to Take Part D Share; Seeing a Leveling Out of Losses at CVH and UAMThis report contains brief updates on the following: AET, CI, CVH, HNT, HS, HUM, UNH, UAM, WCG, WLP. These companies are covered in more detail in separate Daily Notes and/or Company Reports.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 629

03/08/2011

Daily Note

Pages: 4

FL Medicaid Expansion Proposal Introduced in the Senate; Includes ABD/LTC, 90% Minimum MLR, and Member Cost Sharing

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 630

03/03/2011

Company Report

Pages: 9

Price: 24.95

Company: Humana Inc.

Industry: Medical - HMOs

Record: 631

02/28/2011

Company Report

Pages: 6

Company Retains Military Health Care Contract. 2011 EPS Estimate Raised.

Provider: J.J.B. Hilliard, W.L. Lyons

Analyst: O'NEIL S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 632

02/28/2011

Company Report

Pages: 8

Raising 2012 Estimate $0.20 to $7.22 on TRICARE Contract Win

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 633

02/08/2011

Company Report

Pages: 14

Multiple Upside Levers to Guidance; Raising PT to $69, LT Growth Undervalued.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 50.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 634

02/08/2011

Company Report

Pages: 11

Fourth quarter earnings came in below consensus expectations.

Provider: J.J.B. Hilliard, W.L. Lyons

Analyst: O'NEIL S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 635

01/14/2011

Daily Note

Pages: 32

4Q10 Preview: Positive 2011 Outlook for Managed Care; Reiterate UNH and HUM as Top Picks

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 636

01/14/2011

Company Report

Pages: 7

Raising 2010 Estimates on Moderate Utilization; Continue to See Upside to 2011 Guidance.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 637

01/05/2011

Industry Report

Pages: 36

2011 Life Sciences and Healthcare Preview: Macro and Sector Trends; Catalysts; Top Picks.

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 75.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 638

12/22/2010

Company Report

Pages: 7

Guidance Raised $0.10; Continue to See MA and PDP Upside to Guidance.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 639

12/16/2010

Industry Report

Pages: 27

Modest Medicare Growth in December; Expect Strong January Growth to be Driven by Gains.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 640

12/07/2010

Company Report

Pages: 8

Price: 24.95